We performed testing for residual <i>IDH1</i> variants (<i>IDH1</i>m) in pre-transplant CR1 blood of 148 adult patients undergoing alloHCT for <i>IDH1</i>-mutated AML at a CIBMTR site between 2013-2019. Here, IDH1 is linked to acute myeloid leukemia.